Viridian Therapeutics Inc (VRDN)
23.33
+0.27
(+1.17%)
USD |
NASDAQ |
Sep 27, 16:00
23.35
+0.02
(+0.09%)
After-Hours: 20:00
Viridian Therapeutics Revenue (Quarterly): 0.072M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.072M |
| March 31, 2024 | 0.072M |
| December 31, 2023 | 0.072M |
| September 30, 2023 | 0.072M |
| June 30, 2023 | 0.072M |
| March 31, 2023 | 0.098M |
| December 31, 2022 | 0.105M |
| September 30, 2022 | 1.195M |
| June 30, 2022 | 0.256M |
| March 31, 2022 | 0.216M |
| December 31, 2021 | 0.214M |
| September 30, 2021 | 0.208M |
| June 30, 2021 | 1.09M |
| March 31, 2021 | 1.451M |
| December 31, 2020 | 0.054M |
| September 30, 2020 | |
| June 30, 2020 | 0.168M |
| March 31, 2020 | 0.828M |
| December 31, 2019 | 0.88M |
| September 30, 2019 | 0.695M |
| June 30, 2019 | 2.514M |
| March 31, 2019 | 0.372M |
| December 31, 2018 | 0.476M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.944M |
| June 30, 2018 | 2.182M |
| March 31, 2018 | 4.784M |
| December 31, 2017 | 1.192M |
| September 30, 2017 | 1.631M |
| June 30, 2017 | 0.718M |
| March 31, 2017 | 0.462M |
| December 31, 2016 | 0.756M |
| September 30, 2016 | 0.889M |
| June 30, 2016 | 0.874M |
| March 31, 2016 | 0.818M |
| December 31, 2015 | 0.659M |
| September 30, 2015 | 0.501M |
| June 30, 2015 | 0.734M |
| March 31, 2015 | 0.645M |
| December 31, 2014 | 0.655M |
| September 30, 2014 | 1.301M |
| June 30, 2014 | 1.274M |
| March 31, 2014 | 1.091M |
| December 31, 2013 | 1.090M |
| September 30, 2013 | 0.9836M |
| June 30, 2013 | 1.103M |
| March 31, 2013 | 1.139M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.054M
Minimum
Dec 2020
1.451M
Maximum
Mar 2021
0.4115M
Average
0.208M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 14.83M |
| Xtant Medical Holdings Inc | 29.94M |
| Myomo Inc | 7.521M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.99M |
| Total Expenses (Quarterly) | 72.26M |
| EPS Diluted (Quarterly) | -1.02 |
| Enterprise Value | 1.139B |
| Profit Margin (Quarterly) | -90.27K% |
| Earnings Yield | -18.22% |
| Normalized Earnings Yield | -18.22 |